The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Drug Manufacturers - Other > Knoll GmbH

Knoll GmbH
 NEWS FROM THE STANDARD
Bristol-Myers to Buy DuPont Drug Unit for $7.8 Billion
Jun 07 2001 05:22 PM PDT

 PROFILE
Dieters can control their midsections with Knoll's Meridia, a drug touted as supplementing, not replacing, lifestyle changes for the obese. Founded in 1886 and now a subsidiary of Abbott Laboratories (which bought the company from Germany's chemicals giant BASF), Knoll develops and makes drugs to treat pain, heart disease, cancer, autoimmune and nervous system dysfunctions, and other diseases and disorders. Its products include thyroid replacement hormone SYNTHROID, painkiller Vicoprofen, and Isoptin for heart disease. Knoll expands its product portfolio by forming strategic partnerships and marketing collaborations.

 COMPETITION
GlaxoSmithKline plc (GSK)
Johnson & Johnson (JNJ)
Merck & Co., Inc. (MRK)

 FINANCIAL OVERVIEW
Fiscal Year-End: December
1998 Sales (mil.): 690.90
1-Yr. Sales Growth: 5.1%
Employees: 3,205
Revenue per employee: $215,569.42

 KEY PEOPLE
• Dieter Wagner
    CEO

 CONTACT INFO
Knollstrasse 50
67061 Ludwigshafen 67008, Germany
Phone: 49-621-589-0
Fax: 49-621-589-1562
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001